A Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative Colitis
Clinical trial NCT03531892 · COMPLETED
Trial details
- NCT number
- NCT03531892
- Sponsor
- EA Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-06
- Primary completion
- 2020-11-09
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.